Business Trends– category –
-
TSMC Moves to Large-Format Glass Substrates with CoPoS to Address CoWoS Capacity for AI Chips, Targeting 2028-2029 Mass Production
36Kr, Semiconductor Industry Watch, AI Weekly Taiwan Overview TSMC has launched a pilot line for its CoPoS (Chip-on-Panel-on-Substrate) advanced packaging at Taiwan's VisEra, aiming to alleviate the critical CoWoS capacity bottleneck for... -
Heart-Specific LNP Delivery for Myocardial Infarction Remains a Challenge: Conventional LNPs Accumulate in Liver, while Novel Lipid Engineering Targets Lungs and Spleen
American Heart Association Journals USA Overview Lipid nanoparticles (LNPs) are clinically validated non-viral vectors for delivering therapeutics like small molecules, mRNA, and siRNA; however, achieving heart-specific drug delivery for... -
Molecular Glue Development Accelerates: Gluetacs and Degron Advance Key Programs in Targeted Protein Degradation
GlobeNewswire Global Overview The field of molecular glues, a powerful targeted protein degradation (TPD) modality, is rapidly expanding with two significant clinical advancements: Gluetacs Therapeutics has initiated a Phase II trial for... -
Focused Ultrasound and Microbubbles Temporarily Open Blood-Brain Barrier for Enhanced Brain Drug Delivery
Drug Target Review UK Overview The blood-brain barrier (BBB) obstructs most therapeutic agents from reaching the brain, a major hurdle in treating neurological disorders. Researchers are advancing focused ultrasound (FUS), specifically l... -
Kymera Therapeutics’ Oral STAT6 Degrader KT-621 Shows Positive Phase 1b Atopic Dermatitis Data, Potential Injectable Alternative
TradingView Global Overview Kymera Therapeutics' lead candidate, KT-621 (an oral STAT6 degrader leveraging targeted protein degradation), demonstrated positive Phase 1b data in atopic dermatitis. Presented at the American Academy of Derm... -
Non-Endocytic Membrane-Translocating Delivery Strategies Bypass Endosomal Barriers for Gene, mRNA, and Protein Therapies
Drug Target Review UK Overview A new review evaluates non-endocytic membrane-translocating delivery strategies designed to circumvent insufficient endosomal escape efficiency, a major hurdle for many next-generation therapeutics. These e... -
Imperial College Develops Prostate-Targeted mRNA Nanogels, Overcoming Liver Accumulation in Cancer Therapy
Imperial College London UK Overview Researchers at Imperial College London have developed prostate-targeted degradable polymer nanogels for mRNA delivery in prostate cancer treatment. This innovation overcomes the challenge of tissue-spe... -
Bambusa Therapeutics’ Bispecific Antibody BBT001 Achieves Rapid, Durable Itch Relief and AD Improvement in Phase 1 Atopic Dermatitis Trial
Dermatology Times USA Overview Preliminary Phase 1 clinical data for Bambusa Therapeutics' bispecific antibody BBT001 shows rapid and sustained improvement in disease severity and pruritus in moderate-to-severe atopic dermatitis (AD) pat... -
Dove Medical Press Reviews Exosome-Inspired Nanocarriers: Next-Gen Drug Delivery for Cancer Therapy
Dove Medical Press UK Overview Dove Medical Press published a review on exosomes as next-generation bio-derived drug delivery systems for cancer therapy. The review emphasizes exosomes' natural ability to cross biological barriers and th... -
Exosome Drug Delivery and Personalized mRNA Cancer Vaccines Emerge as Top Tech Trends for 2026, Showing Promise in Clinical Trials
Today Tech Times Global Overview Today Tech Times reports that exosome drug delivery systems (DDS) and personalized mRNA cancer vaccines are leading technology trends for 2026. Exosome DDS is the focus of over 200 ongoing clinical trials...
